share_log

歌禮製藥-B：建議授出發行股份及購回股份之一般授權、重選退任董事及股東週年大會通告

ASCLETIS-B: Proposals for General Mandates to Issue Shares and Repurchase Shares, Re-Election of Retiring Directors and Notice of Annual General Meeting

Hong Kong Stock Exchange ·  Apr 26 16:51
Summary by Futu AI
歌禮製藥有限公司（股份代號：1672）將於2024年5月23日舉行股東週年大會，地點為中國浙江省杭州市蕭山區啟迪路198號杭州灣信息港D座11樓。會議將考慮授出發行股份及購回股份之一般授權、重選退任董事等事宜。股東無論能否出席，均需按照代表委任表格指示填妥表格，並於會議前48小時交回。此外，公司亦提供了有關購回股份的詳細資料，包括購回的理由、資金來源及可能對公司財務狀況的影響。董事會目前無即時計劃根據發行授權發行任何股份或根據購回授權購回股份。顧炯先生及華林女士將於大會上輪值退任，並符合資格且願意膺選連任。股東週年大會通告及相關附錄詳情已於公司通函中披露。
歌禮製藥有限公司（股份代號：1672）將於2024年5月23日舉行股東週年大會，地點為中國浙江省杭州市蕭山區啟迪路198號杭州灣信息港D座11樓。會議將考慮授出發行股份及購回股份之一般授權、重選退任董事等事宜。股東無論能否出席，均需按照代表委任表格指示填妥表格，並於會議前48小時交回。此外，公司亦提供了有關購回股份的詳細資料，包括購回的理由、資金來源及可能對公司財務狀況的影響。董事會目前無即時計劃根據發行授權發行任何股份或根據購回授權購回股份。顧炯先生及華林女士將於大會上輪值退任，並符合資格且願意膺選連任。股東週年大會通告及相關附錄詳情已於公司通函中披露。
Song Pharmaceutical Co., Ltd. (stock code: 1672) will hold its Annual General Meeting on 23 May 2024 at the 11th floor of Tower D of Hangzhou Bay Information Port, 198 Qidi Road, Xiaoshan District, Hangzhou City, Zhejiang Province, China. The meeting will consider granting general mandates to issue shares and repurchase shares, re-election of retiring directors, etc. Shareholders are required to complete the form in accordance with the instructions in the Proxy Form and return it 48 hours prior to the Meeting. In addition, the Company has provided details on the repurchase of shares, including the reasons for the repurchase, the source of the funds and the possible impact on the Company's financial condition. The Board of Directors does not currently plan to issue...Show More
Song Pharmaceutical Co., Ltd. (stock code: 1672) will hold its Annual General Meeting on 23 May 2024 at the 11th floor of Tower D of Hangzhou Bay Information Port, 198 Qidi Road, Xiaoshan District, Hangzhou City, Zhejiang Province, China. The meeting will consider granting general mandates to issue shares and repurchase shares, re-election of retiring directors, etc. Shareholders are required to complete the form in accordance with the instructions in the Proxy Form and return it 48 hours prior to the Meeting. In addition, the Company has provided details on the repurchase of shares, including the reasons for the repurchase, the source of the funds and the possible impact on the Company's financial condition. The Board of Directors does not currently plan to issue any shares pursuant to the issuance authorization or to repurchase shares under the repurchase authorization. Mr. Gu Jiong and Ms. Wah Lin will retire on the first round of the General Meeting and are eligible and willing to run for office consecutively. Details of the Notice of Annual General Meeting and related Appendices have been disclosed in the Company's Circular.

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.